24/7 Market News Snapshot 19 December, 2024 – Mangoceuticals, Inc. Common Stock (NASDAQ:MGRX)

December 19, 2024

DENVER, Colo., 19 December, 2024 (247marketnews.com) – (NASDAQ:MGRX) are discussed in this article.
Mangoceuticals, Inc. (MGRX) has demonstrated remarkable momentum in the market, opening at $2.45 and experiencing a surge of over 30% to reach $3.188, driven by a formidable trading volume of 574.16K. This upward trajectory indicates strong investor confidence and highlights MGRX’s potential as a lucrative investment opportunity.

Complementing this market enthusiasm, Mangoceuticals has made a significant strategic move with the acquisition of an innovative patent for mushroom-derived compositions. This acquisition is aimed at enhancing overall health and wellness and is a testament to the company’s commitment to pioneering natural solutions within the burgeoning nutraceutical sector. The newly obtained patent (WO 2023/086647 PCT/US2022/049857) includes a wide array of nutraceutical formulations derived from functional mushrooms, such as Cordyceps sinensis, Ganoderma lucidum (Reishi), and Hericium erinaceus (Lion’s Mane). These compositions are designed to support immune health, cognitive function, mood stabilization, and appetite control, among other benefits.

Jacob Cohen, the Founder and CEO of MangoRx, expressed that this acquisition signifies a critical milestone in their pursuit of innovative wellness solutions. With the global functional mushroom market projected to grow from USD 32.41 billion in 2024 to USD 48.59 billion by 2029, this advancement positions MangoRx strategically within a rapidly expanding industry.

Plans are underway to harness this patent to launch a new line of wellness products, including dietary supplements and functional foods addressing various health needs. The company’s focus on scientifically validated formulations underscores its dedication to quality and efficacy, positioning MangoRx as a key player in the evolving landscape of health and wellness solutions. Investors and stakeholders are encouraged to monitor the company’s developments closely as it advances in this dynamic market.

Related news for (MGRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.